La lipoproteine(A) est-elle athérogène ? = Is lipoprotein a atherogenicMOOSER, V; DARIOLI, R.Médecine et hygiène. 1998, Vol 56, Num 2200, pp 504-508, issn 0025-6749, 3 p.Article

Formes monogéniques de dyslipidémie : à l'interface entre le laboratoire, le praticien et le patient : Cardiologie préventive = Monogenic forms of lipid disorder: at the interface between the laboratory, the physician and the patientMOOSER, V; DARIOLI, R.Médecine et hygiène. 2002, Vol 60, Num 2383, pp 553-558, issn 0025-6749, 4 p.Article

L'hyperlipidémie familiale combinée : Une affection fréquente, athérogène et méconnue = Familial combined hyperlipidemia : A frequent, atherogenic and poorly understood lipid disorderMOOSER, V; RODONDI, N; DARIOLI, R et al.Médecine et hygiène. 1999, Vol 57, Num 2245, pp 489-494, issn 0025-6749, 4 p.Article

PsyCoLaus: santé mentale et maladies cardiovasculaires: association fortuite? : MEDECINE INTERNE = PsyCoLaus: mental disorders and cardio- ( vascular diseases: spurious association?PREISIG, M; WAEBER, G; MOOSER, V et al.Revue médicale suisse. 2011, Vol 7, Num 315, pp 2127-2129, issn 1660-9379, 3 p.Article

Marqueurs biologiques des statuts vitaminiques B12 et D: aspects analytiques d'importance clinique : Vitamines, antioxydants, oligoéléments et polypill pour tout le monde ? = Biological markers for the status of vitamins B12 and D: the importance of some analytical aspects in relation to clinical interpretation of resultsREY, F; REY, F; REY, F; REY, F; MOOSER, V et al.Revue médicale suisse. 2012, Vol 8, Num 360, issn 1660-9379, 2052-2058 [6 p.]Article

Sommes-nous prêts à prescrire une polypill à nos patients? : Vitamines, antioxydants, oligoéléments et polypill pour tout le monde ? = Are we ready to prescribe a Polypill to our patients?CASTIONI, J; MOOSER, V; WAEBER, G et al.Revue médicale suisse. 2012, Vol 8, Num 360, issn 1660-9379, 2046-2051 [5 p.]Article

Prédire la survenue d'un diabète: la place de scores cliniques et/ou génétiques : Médecine interne = Genetic and/or clinical scores to anticipate the onset of diabetesWAEBER, G; MOOSER, V; VOLLENWEIDER, P et al.Revue médicale suisse. 2009, Vol 5, Num 223, issn 1660-9379, 2136-2141 [5 p.]Article

Atypical depression and alcohol misuse are related to the cardiovascular risk in the general populationGLAUS, J; VANDELEUR, C; MOOSER, V et al.Acta psychiatrica scandinavica. 2013, Vol 128, Num 4, pp 282-293, issn 0001-690X, 12 p.Article

The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetesWAEBER, G; DELPLANQUE, J; VIONNET, N et al.Nature genetics. 2000, Vol 24, Num 3, pp 291-295, issn 1061-4036Article

Interactions between apolipoprotein E and Apolipoprotein(a) in patients with late-onset Alzheimer diseaseMOOSER, V; HELBECQUE, N; MIKLOSSY, J et al.Annals of internal medicine. 2000, Vol 132, Num 7, pp 533-537, issn 0003-4819Article

Lipoprotein(a) in the nephrotic syndrome : Molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urineDOUCET, C; MOOSER, V; GONBERT, S et al.Journal of the American Society of Nephrology. 2000, Vol 11, Num 3, pp 507-513, issn 1046-6673Article

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitorsPERIARD, D; TELENTI, A; MOOSER, V et al.Circulation (New York, N.Y.). 1999, Vol 100, Num 7, pp 700-705, issn 0009-7322Article

Reduction in left ventricular mass in normotensive and spontaneously hypertensive rats given enalaprilMOOSER, V; CASLEY, D; TRINDER, D et al.Clinical and experimental pharmacology and physiology. 1991, Vol 18, Num 5, pp 341-344, issn 0305-1870Conference Paper

Alcohol drinking, the metabolic syndrome and diabetes in a population with high mean alcohol consumptionCLERC, O; NANCHEN, D; RODONDI, N et al.Diabetic medicine. 2010, Vol 27, Num 11, pp 1241-1249, issn 0742-3071, 9 p.Article

Répercussions de la sédentarité sur le profil des facteurs de risque cardiovasculaire et le risque d'accident coronarien chez les employés d'entreprises du canton de Vaud : Cardiologie préventive = Repercussion of sedentarity on the cardiovascular risk profile among employees of companies in Vaud County in Western SwitzerlandDARIOLI, R; MOOSER, V; PERDRIX, J et al.Médecine et hygiène. 2002, Vol 60, Num 2383, pp 567-572, issn 0025-6749, 5 p.Article

Major reduction in plasma Lp(a) levels during sepsis and burnsMOOSER, V; BERGER, M. M; TAPPY, L et al.Arteriosclerosis, thrombosis, and vascular biology. 2000, Vol 20, Num 4, pp 1137-1142, issn 1079-5642Article

High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease : implications for plasma Lp(a) assayMOOSER, V; MARCOVINA, S. M; JINPING WANG et al.Clinical genetics. 1997, Vol 52, Num 5, pp 387-392, issn 0009-9163Conference Paper

Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levelsMANCINI, F. P; MOOSER, V; GUERRA, R et al.Human molecular genetics (Print). 1995, Vol 4, Num 9, pp 1535-1542, issn 0964-6906Article

Determinants of angiotensin II generation during converting enzyme inhibitionJUILLERAT, L; NUSSBERGER, J; MENARD, J et al.Hypertension (Dallas, Tex. 1979). 1990, Vol 16, Num 5, pp 564-572, issn 0194-911X, 9 p.Article

Modulation of the renin-angiotensin system by atrial natriuretic peptideJOHNSTON, C. I; PHILLIPS, P. A; ARNOLDA, L et al.Journal of cardiovascular pharmacology. 1990, Vol 16, pp S43-S46, issn 0160-2446, SUP7Conference Paper

Genomic organization, fine-mapping, and expression of the human Islet-Brain 1 (IB1)/C-Jun-Amino-Terminal kinase interacting protein-1 (JIP-1) geneMOOSER, V; MAILLARD, A; BONNY, C et al.Genomics (San Diego, Calif.). 1999, Vol 55, Num 2, pp 202-208, issn 0888-7543Article

La maladie coronarienne est-elle héréditaire ? Plaidoyer en faveur de l'anamnèse familiale, un des piliers de la cardiologie préventive = Is coronary heart disease a genetic disorder ?MOOSER, V; RODONDI, N; VASSALLI, G et al.Médecine et hygiène. 1998, Vol 56, Num 2213, pp 1239-1246, issn 0025-6749, 4 p.Article

Chlorophyll catabolism. III: Structure elucidation and partial synthesis of a new red bilin derivative from Chlorella protothecoidesITURRASPE, J; ENGEL, N; MATZINGER, P et al.Photochemistry and photobiology. 1993, Vol 58, Num 1, pp 116-119, issn 0031-8655Article

Isolation and characterization of the rat liver AVP receptor using [¹²⁵][d(CH₂)₅'sarcosine⁷]AVP¹TRINDER, D; KELLY, J. M; FERNLEY, R et al.Clinical and experimental pharmacology and physiology. 1992, Vol 19, Num 4, pp 253-260, issn 0305-1870Article

Infusion of atrial natriuretic peptide to patients with congestive heart failureGOY, J. J; WAEBER, B; NUSSBERGER, J et al.Journal of cardiovascular pharmacology. 1988, Vol 12, Num 5, pp 562-570, issn 0160-2446Article